High level of beta-type transforming growth factor activity in human urine obtained from cancer patients. 1986

R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda

Activity of transforming growth factor (TGF) in urine was examined by the use of cloned BALB/3T3 A31-1-1 indicator cells. When urine was extracted by an acid-ethanol method, fractionated on a Bio-Gel P-100 column, and analyzed for TGF activity, samples from healthy persons showed no activity, but 80% of the samples from advanced cancer patients had the activity. Activity observed in tumor-bearing patients was eliminated after therapy. Further analysis was carried out in a much simpler way by the fractionation of urine samples after only dialysis and lyophilization. An extensive survey of TGF activity in urine using BALB/3T3 indicator cells revealed weak or intermediate (19%) activity in healthy persons and high (56%) or intermediate (31%) activity in advanced cancer patients. When urine samples were analyzed and compared using both BALB/3T3 cells and NRK 49F cells, the BALB/3T3 cells were shown to form colonies in response to beta-type TGF but not to alpha-type TGF. The present results are the first demonstration of an elevated level of beta-type TGF in urine from cancer patients.

UI MeSH Term Description Entries
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
November 1987, Biochemical and biophysical research communications,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
October 1995, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
July 1994, Cancer,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
December 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
January 1983, Cancer research,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
January 1987, Methods in enzymology,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
January 1985, Journal of cellular biochemistry,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
March 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
January 1988, Ukrainskii biokhimicheskii zhurnal (1978),
R Nishimura, and H Okumura, and K Noda, and H Yasumitsu, and M Umeda
November 1988, Biochemical and biophysical research communications,
Copied contents to your clipboard!